Previous studies have demonstrated that β-glucans play an essential role in innate immune responses, and the mechanism in cancer therapy was mainly via stimulation of macrophages and priming of neutrophil complement receptor 3 for eliciting CR3-dependent cellular cytotoxicity of iC3b-opsonized tumor cells [34], [35], [36]. The gene discussed is CRIPTO3; the disease is cancer.